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Abstract: The ergot alkaloid biosynthesis system has become an excellent model to study 
evolutionary diversification of specialized (secondary) metabolites. This is a very diverse 
class of alkaloids with various neurotropic activities, produced by fungi in several orders of 
the phylum Ascomycota, including plant pathogens and protective plant symbionts in the 
family Clavicipitaceae. Results of comparative genomics and phylogenomic analyses reveal 
multiple examples of three evolutionary processes that have generated ergot-alkaloid 
diversity: gene gains, gene losses, and gene sequence changes that have led to altered 
substrates or product specificities of the enzymes that they encode (neofunctionalization). 
The chromosome ends appear to be particularly effective engines for gene gains, losses and 
rearrangements, but not necessarily for neofunctionalization. Changes in gene expression 
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could lead to accumulation of various pathway intermediates and affect levels of different 
ergot alkaloids. Genetic alterations associated with interspecific hybrids of Epichloë species 
suggest that such variation is also selectively favored. The huge structural diversity of ergot 
alkaloids probably represents adaptations to a wide variety of ecological situations by 
affecting the biological spectra and mechanisms of defense against herbivores, as evidenced 
by the diverse pharmacological effects of ergot alkaloids used in medicine. 
Keywords: Claviceps; Epichloë; Periglandula; Clavicipitaceae; gene clusters; 
chanoclavine; ergopeptine; subterminal; natural products; secondary metabolism 
 
1. Importance of Ergot Alkaloids 
Ergot alkaloids are well known mycotoxins that can contaminate food and feed but also can serve as 
starting materials for important pharmaceuticals. The ergot fungi, for which these alkaloids are named, 
have been responsible for historic episodes of mass poisoning. In Middle-Age Europe, ingestion of rye 
grain or flour that was contaminated with ergots—the resting stage (sclerotia) of Claviceps purpurea—
led to multiple episodes of disfiguring and deadly poisoning of local populations. Historic events 
associated with ergot poisoning include the first Crusade [1], the Salem witch trials (and others) [2–4], 
and the interrupted 1722 Russian campaign (under Peter the Great) against the Ottoman empire [5].  
In modern times, ergot-alkaloid poisoning occasionally occurs through their medicinal use [6], but mass 
ergot poisonings of humans are rare, having last been reported in the 1970s [7,8]. Ergot alkaloid toxicity 
is still a significant problem with livestock, both due to ergot contaminated feed and naturally  
infested forage or rangeland grasses—such as tall fescue (Lolium arundinaceum), sleepygrass  
(Achnatherum robustum) and drunken horse grass (Achnatherum inebrians)—which can be symbiotic 
with seed-transmissible Epichloë species that are capable of producing ergot alkaloids [9–11]. 
Over the past two decades, ergot alkaloids have been tapped for increasingly diverse medical uses. 
The ergopeptine ergotamine is used to treat migraines [12], and other natural and semisynthetic 
ergopeptines and dihydroergopeptines have been used for diseases of the brain. For example, 
bromocriptine (2-bromo-ergocryptine) is used as a component in treatment of Parkinsonism [13] and 
bromocriptine, or the extensively substituted dihydrolysergic acid amide, cabergoline, is used in 
treatment of prolactinoma, a benign adenoma of the pituitary gland [14,15]. Ergot alkaloids are also of 
social relevance because a semisynthetic alkaloid, lysergic acid diethylamide (LSD), is an illicit drug 
that is by far the most potent hallucinogen known. LSD had a major impact on the countercultural and 
hippie movements of the 1960s, since Albert Hofmann first produced it and noted its properties [16]. 
2. Structural Content of Ergot Alkaloid Biosynthesis (EAS) Loci Define Alkaloid Potential 
The ergot alkaloids represent a diverse class of natural products that are generally divided into three 
subclasses: the simpler clavines, lysergic acid and its simple amides, and the highly complex 
ergopeptines. Figure 1 shows the simpler clavines in blue, green, and purple, and the lysergic acid and 
simple amides and ergopeptines both in red, reflective of the orders of biosynthetic steps: blue for early, 
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green for middle, and purple and red for late steps in different fungal families. Clavines are tricyclic or 
tetracyclic compounds known from the fungal families Clavicipitaceae (order Hypocreales) and 
Trichocomaceae (Eurotiales), with the latter showing more variation due to hydroxylation, prenylation 
and acetylation (reviewed in [17]). The presence of EAS clusters in the Arthrodermataceae (Onygenales) 
suggests that they also may produce clavines, a possibility that is supported by the demonstration of 
chanoclavine I dehydrogenase activity of the Arthroderma benhamiae EasD ortholog (GenBank 
accession EFE37118.1) [18]. Lysergic acid and the lysergic acid amides are tetracyclic compounds with 
a common ergolene core, whereas ergopeptines are lysergic acid-tripeptide derivatives. These more 
complex ergot alkaloids are almost exclusively known from Clavicipitaceae, although an ergopeptine 
has also been reported from a Dicyma sp. (Xylariaceae, Xylariales) [19]. 
All known ergot alkaloid biosynthesis genes are present in the genomes of ascomycetous fungi 
grouped either in a single ergot alkaloid synthesis (EAS) cluster or divided into two EAS clusters  
(Figure 2). The particular forms and overall profile of ergot alkaloids produced by a fungus are 
determined by the presence or absence of pathway genes and, for several EAS genes, the particular 
enzyme isoforms they encode. The basic functions have been determined for all known EAS genes in 
the Clavicipitaceae, and most in the Trichocomaceae (reviewed in [20]), so that detecting gene presence 
or absence provides considerable power to predict alkaloid profiles, but there is also important variation 
in substrate and product specificities of some EAS gene-encoded enzymes, which we are not yet able to 
infer from the gene sequences [17]. 
2.1. Genes Encoding the Early Pathway Steps 
The four conserved early pathway steps for all natural ergot alkaloids produce chanoclavine I (CC) 
(recently reviewed [20]), and are catalyzed by enzymes encoded in the four genes: dmaW, encoding 
dimethylallyltryptophan synthase, easF, encoding dimethylallyltryptophan N-methyltransferase, easC, 
encoding a catalase, and easE, encoding chanoclavine-I synthase. Some strains, such as E. elymi E56, 
produce CC as the pathway end-product because they contain functional copies only of these four genes 
in an EAS cluster, which we designate as EASCC (Figure 2; Table 1). Based on similar complements in 
their genomes, we would predict that E. brachyelytri E4804 and Atkinsonella hypoxylon B4728 are also 
CC producers, though CC has not been detected in plants infected with B4728. Strains capable of making 
complex ergot alkaloids also can generate substantial levels of CC and other intermediates and spur 
products as a result of inherent pathway inefficiency, a property suggested to have selective  
advantage [21,22]. 
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Figure 1. The ergot alkaloid pathway showing steps that result in diversification of 
compounds. Pathway steps are color-coded based on the position or diversification within 
the pathway, Blue = early steps to the intermediate chanoclavine, Green = mid steps leading 
to the tetracyclic clavines, Red = late steps represented by the lysergic acid amides and the 
complex ergopeptines, Purple = steps to fumigaclavines produced by Trichocomaceae. 
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Figure 2. Relative adenine and thymine (%AT) DNA content of ergot alkaloid synthesis (EAS) 
loci. Gene name abbreviations are as follow: all eas genes = last letter, cloA = B and dmaW = 
W. Gene names are colored to represent the stage of the pathway for the encoded product (see 
Figure 1). Pseudogenes are represented by Ψ and white-filled arrows. The major pathway end 
product of each strain is indicated on the right in bold face (product produced) or regular type 
(product predicted but not yet tested), or in parentheses (product predicted but undetected). 
Arrows marked with * represent orthologues of C. purpurea AET79176 (GenBank). Cyan 
bars indicate repeats, and vertical black bars indicate miniature inverted-repeat transposable 
elements (MITEs). Where present, telomeres are positioned at left. 
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Table 1. Ergot alkaloid synthesis (EAS) gene names and encoded functions. 
Gene name a Enzyme EASCC EASEC EASERP EASLAH EASEN/ERP EASLAH/ERP EASFC 
dmaW Dimethylallyltryptophan synthase + + + + + + + 
easF Dimethylallyltryptophan N-methylase + + + + + + + 
easC Catalase + + + + + + + 
easE Chanoclavine-I synthase + + + + + + + 
easD Chanoclavine-I dehydrogenase  + + + + + + 
easA b Chanoclavine-1 aldehyde oxidoreductase  + iso + iso + iso + iso + iso + red 
easG agroclavine, festuclavine or pyroclavine dehydrogenase  + + + + + + 
cloA b agroclavine, festuclavine, or elymoclavine monooxygenase  + + + + +  
lpsB lysergyl peptide synthetase subunit 2   + + + +  
lpsA b lysergyl peptide synthetase subunit 1   +  + +  
easH ergopeptide lactam hydroxylase   +  + +  
lpsC lysergyl peptide synthetase and reductase subunit    + + +  
easO c putative ergonovine oxygenase    +  +  
easP c putative LAH synthase    +  +  
easM c possible festuclavine 9-monooxygenase       + 
easK c possible festuclavine 9-monooxygenase       + 
easN fumigaclavine acetylase       + 
easL fumigaclavine reverse prenyltransferase       + 
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a Pathway steps are color-coded based on the positions within the pathway as shown in Figure 1; b Specificity of encoded gene can vary. EasA functions as either an isomerase 
“+ iso” or reductase “+ red”; c Actual role not confirmed. 
 
Toxins 2015, 7 1279 
 
 
2.2. Diversification of the EAS Pathways 
Beyond the production of CC, multiple biosynthetic pathways begin to branch and diverge  
(Figure 1), and the chemotypic variation between and even within species is reflected in the gene content 
of each EAS locus known or predicted to direct biosynthesis of such pathway end-products as elymoclavine 
(EC), lysergic acid α-hydroxyethylamide (LAH), ergonovine (EN), and ergopeptines such as ergovaline 
(ERV), ergotamine (ERA), ergocryptine (ERK) or ergobalansine (ERB). Where clarification is needed, 
we will designate the various EAS clusters with superscripts reflecting end products, as EASEC, EASLAH or 
EASEN, as well as EASERP for ergopeptine producers, EASEN/ERP for producers of EN and ergopeptines, and 
EASLAH/ERP for producers of LAH and ergopeptines. Compared to EASEN, EASLAH has two additional 
genes, easO and easP, suggesting that EN may be the LAH precursor. Fungi with EASLAH clusters also 
tend to accumulate substantial levels of ergine, probably by spontaneous hydrolysis of LAH [23].  
The EASEN/ERP cluster in the most infamous ergot fungus, Claviceps purpurea, and the EASLAH/ERP cluster 
in the morning-glory symbiont, Periglandula ipomoeae, are the only ones identified to date that 
determine synthesis of three different ergot alkaloid subclasses [24]. 
2.2.1. Completion of the Tetracyclic Ergolene Common Core 
The EAS pathway diversifies at multiple steps depending, not only on presence or absence of genes, 
but also on the substrate- and product-specificities of several of the encoded enzymes [17,20]  
(Figure 1). Once CC is oxidized by the action of the EasD enzyme to form chanoclavine aldehyde, EasA 
then catalyzes a reduction step that allows rotation around the C8-C9 bond so that an iminium ion (i.e., 
Schiff base) can form as the first step in the synthesis of the D-ring of the ergolene core common to most 
ergot alkaloids. Surprisingly, this is one of the steps at which different pathways can diverge to give 
either ergot alkaloids or dihydroergot alkaloids [17,25]. EasA proteins that follow the reduction step 
with reoxidation are effectively isomerases, typically found in Claviceps purpurea and many species of 
Balansia, Epichloë and Periglandula. In contrast, EasA isoforms that only reduce the C8-C9 bond direct 
the pathway toward dihydroergot alkaloids, such as those found in Claviceps africana and  
Claviceps gigantea as well as in the fumigaclavine producer, Neosartorya fumigata. 
The ergolene D-ring is completed by a reduction catalyzed by EasG, to yield agroclavine (for ergot 
alkaloids) or festuclavine (for dihydroergot alkaloids) [20] (Figure 1). After the D-ring is closed,  
the C8-linked methyl group can be oxidized by the action of a cytochrome P450 monooxygenase.  
This enzyme, designated CloA, apparently represents another point in the pathway where variation in an 
enzyme can affect the alkaloid profile [17]. It appears likely that different isoforms of CloA determine 
the level of oxidation, such that CloA of C. fusiformis catalyzes the 2-electron oxidation of agroclavine 
(AC) to EC, whereas CloA of C. purpurea and many other Clavicipitaceae catalyzes a 6-electron 
oxidation of agroclavine to paspalic acid or lysergic acid (LA). Whether LA is generated spontaneously 
or enzymatically from paspalic acid remains unclear. 
2.2.2. Formation of Lysergic Acid, Lysergic Acid Amides and Complex Ergopeptines 
Despite its fame as a starting material for laboratory synthesis of LSD, LA does not generally occur 
in appreciable concentrations in natural systems [22]. This is because fungi that make LA are usually 
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capable of converting it to any of a multitude of lysergic acid amides, ranging from the simplest  
(ergine = lysergic acid amide) to complex ergopeptines in which LA has an amide linkage with a tricyclic 
moiety derived from three additional amino acids (Figure 1) (reviewed in [17]). This divergence point 
involves a remarkable system that centers on the enzyme subunit LpsB (=LPS2) plus one or both of its 
partner subunits LpsA (=LPS1) or LpsC (=LPS3) depending on whether functional lpsA or lpsC genes 
are present [26]. Each of the Lps subunits contains modules that contribute specific catalytic activities 
and, in combination with other Lps subunits, comprise multi-enzyme complexes called nonribosomal 
peptide synthetases (NRPSs). Each module AMPylates and thio-esterifies an amino acid, and then 
condenses it with the similarly processed amino acid on the adjacent module. LpsB specifies LA, 
whereas LpsC specifies L-alanine (Ala). LpsC also has a C-terminal “R*” domain (cd05235: SDR_e1) 
that catalyzes reductive release of the LA-Ala conjugate as EN. Alternatively, if LpsB partners with 
LpsA they form the enzyme complex required for formation of ergopeptide lactams, which are then 
oxidatively cyclized by the action of EasH [27] to form ergopeptines or their 8(R) isomers, the 
ergopeptinines. The particular composition of each ergopeptine is determined by specificity of each of 
the three modules in LpsA for its cognate amino acid [28], so far giving 21 different combinations  
(Table 2) [19,29,30]. For example, Epichloë strains that produce ergovaline (ERV) have LpsAAVP (where 
the superscripts are single-letter codes for the amino acids specified, in order, by the first, second and 
third modules of LpsA). In contrast, C. purpurea strain 20.1 has genes for the LpsA isoforms LpsAAFP 
and LpsAVLP, which determine production of ergotamine (ERA) and ergocryptine (ERK), respectively. 
There are 19 ergopeptines known, most with corresponding ergopeptinines, which are their 8(S) 
stereoisomers. Two additional ergopeptinines have no known 8(R) isomers (reviewed in [30]). 
Additionally, Claviceps africana produces dihydroergosine, which is similar to ergosine except that it 
has a saturated D-ring, presumably because it is derived from festuclavine rather than agroclavine 
(reviewed in [17]). 
2.2.3. Fumigaclavine Production by the Trichocomaceae 
The Trichocomaceae produce various clavines derived from festuclavine (reviewed in [17])  
(Figure 1). They lack agroclavine or its derivatives because they have a reducing rather than isomerizing 
EasA isoform. They may also produce pyroclavine, the 8(S) stereoisomer of festuclavine, due to 
functional differences in EasG [31]. Further modifications are catalyzed by enzymes encoded in the EAS 
cluster of N. fumigata, for which orthologs are not found in other fungi, giving rise to the fumigaclavines. 
The 9-hydroxylation is probably catalyzed by either EasM or EasK, both predicted to be cytochrome 
P450. Then O-acetylation is catalyzed by EasN, and the “reverse” prenylation step is catalyzed by EasL. 
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Table 2. Lysergic acid-linked substituents of natural ergopeptines a. 
Ergopeptine AA1 R1 AA2 R2 AA3 R3 
Ergotamine (ERA) Ala Me Phe CH2Ph Pro prolyl (CH2)3 
Ergovaline (ERV) Ala Me Val i-Pr Pro prolyl (CH2)3 
Ergosine Ala Me Leu i-Bu Pro prolyl (CH2)3 
Dihydroergosine b Ala Me Leu i-Bu Pro prolyl (CH2)3 
β-Ergosine Ala Me Ile sec-Bu Pro prolyl (CH2)3 
Ergosedmine Ile sec-Bu Leu i-Bu Pro Prolyl (CH2)3 
Ergobine Ala Me ABA Et Pro prolyl (CH2)3 
Ergocristine Val i-Pr Phe CH2Ph Pro prolyl (CH2)3 
Ergocornine Val i-Pr Val i-Pr Pro prolyl (CH2)3 
Ergocryptine c,d (ERK) Val i-Pr Leu i-Bu Pro prolyl (CH2)3 
β-Ergocryptine d Val i-Pr Ile sec-Bu Pro prolyl (CH2)3 
γ-Ergocryptinine c,e Val i-Pr norLeu n-Bu Pro prolyl (CH2)3 
Ergobutyrine Val i-Pr ABA Et Pro prolyl (CH2)3 
Ergoladinine e Val i-Pr Met EtSCH3 Pro prolyl (CH2)3 
Ergogaline Val i-Pr homoIle 2-Me-n-Bu Pro prolyl (CH2)3 
Ergostine ABA Et Phe CH2Ph Pro prolyl (CH2)3 
Ergonine ABA Et Val i-Pr Pro prolyl (CH2)3 
Ergoptine c ABA Et Leu i-Bu Pro prolyl (CH2)3 
β-ergoptine ABA Et Ile sec-Bu Pro prolyl (CH2)3 
Ergobutine ABA Et ABA Et Pro prolyl (CH2)3 
Ergobalansine (ERB) Ala Me Leu i-Bu Ala Me 
Unnamed, from Dicyma sp. Ala Me Leu i-Bu Phe CH2Ph 
a Abbreviations: AA= amino acid position; ABA = 2-aminobutyric acid, norLeu = L-norleucine;  
homoIle = L-homoisoleucine. Other L-amino acids and R-groups are abbreviated as standard; b Dihydroergosine 
has a saturated D-ring, whereas others listed here have a 9-10 double bond; c Synonyms: ergosine = α-ergosine, 
ergocryptine = α-ergocryptine, ergoptine = α-ergoptine; d Synonyms: α-, β-, or γ-ergocryptine = α-, β-,  
or γ-ergokryptine, respectively; e Only the 8(R) (=isolysergyl) isomers—namely, ergoladinine and  
γ-ergocryptinine—have been reported to date. 
2.3. Contents of the EAS Loci 
The EAS pathway specificity mentioned above is reflected in the structural content of EAS loci across 
the Clavicipitaceae, which varies based on presence or absence of genes that correspond to ergot alkaloid 
biosynthetic capability within a given strain. The most EAS genes (14) are present in P. ipomoeae, which 
produces ergobalansine (ERB), EN and LAH, whereas only four EAS genes are common to all strains 
that are capable or predicted to produce CC [24]. Interestingly, those four early-pathway genes are 
grouped together in the N. fumigata cluster, whereas the mid-pathway genes for festuclavine 
biosynthesis are interspersed with late-pathway genes for fumigaclavine [32,33] (Figure 2). The gene 
arrangements differ between N. fumigata and the Clavicipitaceae, and also differ considerably between 
Epichloë spp. and other Clavicipitaceae. In At. hypoxylon, Balansia obtecta, the Claviceps spp.,  
Epichloë inebrians (formerly Epichloë gansuensis var. inebrians; [34]) and P. ipomoeae, early and  
mid-pathway genes (except for easA) are interspersed, whereas the late genes (lps genes, easH, easO 
and easP) are at the EAS-cluster periphery, separated from the main EAS cluster, fatally mutated or 
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missing. The easA gene is the exception among mid-pathway genes, being located between late-pathway 
genes lpsB and lpsC in these species. In the other Epichloë species, there is similar variation in gene 
content and functionality, but greater variation in gene arrangement even for early- and late-pathway 
genes. Clearly, strains that produce only CC are derived by losses of mid-and late-pathway genes, 
because remnants and pseudogenes often remain in their genomes. 
Putative EAS genes can be identified in fungal genome sequences using bioinformatics pipelines 
developed to identify core secondary metabolite genes encoding NRPSs, polyketide synthases (PKS), 
prenyltransferases (dmaW homologues) or terpene cyclases and mixed or hybrid versions [35–37].  
The EAS gene clusters such as EASCC can sometimes be identified within the prenyltransferase or terpene 
cyclase group, whereas a more complex EAS cluster, such as EASERP, will fall into a hybrid or mixed 
category since they contain sequences for both prenyltransferases and NRPSs [38]. In genomes of several 
Trichophyton and Arthroderma species (Arthrodermataceae), apparent orthologues of dmaW, easF, 
easC, easE and easD are identifiable in a cluster [18]. Genes flanking this cluster match signatures of 
various biosynthetic functions, so it may well be that Arthrodermataceae produce one or more alkaloid 
subclasses yet to be identified. The EAS gene complements and structural arrangements identified in 
Metarhizium robertsii [39] are very similar to E. inebrians and, as such, we would predict that  
M. robertsii strain ARSEF 23 could be capable of producing EN and LAH, assuming there is similar 
specificity of LpsB with LA and LpsC with alanine. 
3. Phylogenetic Relationships of EAS Genes 
3.1. Comparison of EAS Gene Phylogenies 
We have inferred phylogenetic trees for EAS genes of known and suspected ergot alkaloid-producing 
Clavicipitaceae, plus N. fumigata, which we presumed to be an outgroup in keeping with housekeeping 
gene relationships. Phylogenies of the core genes for the first four steps in ergot alkaloid  
biosynthesis—namely, dmaW, easF, easC and easE—were congruent, so a concatenated data set (WFCE) 
was constructed, from which a maximum likelihood (ML) tree was inferred with PhyML at  
phylogeny.fr [40] (Figure 3). The lpsB tree (Figure 4) was also congruent with the corresponding WFCE 
subtree (i.e., the tree pruned of taxa lacking lpsB). The WFCE and lpsB phylogenies were significantly 
supported at all nodes. The WFCE phylogeny grouped sequences from seven out of eight Epichloë 
species in a clade that was basal in the Clavicipitaceae, whereas the sequences from the eighth 
representative, E. inebrians, appeared as the sister to the Claviceps clade. Comparing this phylogeny to 
that of the housekeeping gene, tefA (Figure 5), the only significant disparity was the basal placement of 
the main clade of Epichloë EAS genes, which contrasted with the tefA phylogeny that placed all of the 
Epichloë species together in a clade with a sister relationship to the Claviceps clade. There was also a 
possible disparity in placement of P. ipomoeae, but this cannot be considered significant because the 
relevant branch in the tefA tree lacked statistical support. Therefore, with the glaring exception of the 
main Epichloë EAS clade, evolution of EAS genes in the Clavicipitaceae appears to have been by direct 
decent without duplication (paralogy) or horizontal gene transfer. 
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Figure 3. Phylogeny of concatenated dmaW-easF-easC-easE genes. The phylogenetic tree 
is based on a nucleotide alignment of coding sequences of the core genes for the first four 
steps in ergot alkaloid biosynthesis available from sequenced genomes. Sequences were 
aligned with MUSCLE [41], and trees were inferred by maximum likelihood with PhyML 
implemented by Phylogeny.fr [40]. Node support was determined by the approximate 
likelihood ratio test [42]. Gene gains and loses are indicated by + and –, respectively, and 
asterisks (*) indicate that remnants or pseudogenes can be found in one or more members of 
the clade. Genes are color-coded based on position of the encoded step within the pathway. 
The major pathway end product of each strain is indicated on the right in bold face  
(product produced) or regular type (product predicted but not yet tested), or in parentheses 
(product predicted but undetected). 
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Figure 4. Phylogeny of lysergyl peptide synthetase subunit 2 (lpsB). The phylogenetic tree 
was inferred by maximum likelihood on a nucleotide alignment of coding sequences. 
Methods are as in Figure 3. The left edge is placed to correspond to the root inferred in Figure 3 
with Neosartorya fumigata EAS genes as the outgroup; N. fumigata lacks lpsB. 
 
Figure 5. Phylogeny of tefA, encoding translation elongation factor 1-α. The phylogenetic 
tree inferred by maximum likelihood on a nucleotide alignment of coding sequences. 
Methods are as in Figure 3. 
The well-supported position of EAS genes from most Epichloë species, being basal among the 
Clavicipitaceae (Figures 3 and 4) indicates a deviation from strict orthology because it differs 
dramatically from housekeeping gene phylogenies (Figure 5). Possible causes of this deviation are  
trans-species polymorphism, paralogy or horizontal gene transfer. In a BLASTp search of dmaW against 
available sequences at GenBank, no homologues were closely related to this clade except those of other 
Epichloë species, so there was no obvious source for a horizontal gene transfer event. Comparing the 
genomic context, sequences nearest the EAS clusters differed between E. festucae and E. inebrians 
(assemblies of other Epichloë species did not link EAS clusters with other genes), so trans-species 
polymorphism also was unsupported. This leaves, as our favored possibility, that the E. inebrians and 
other Epichloë EAS clusters were derived from paralogous copies that arose from duplication of the EAS 
cluster in an ancestor to most or all of the Clavicipitaceae. In this regard, the tefA phylogeny (Figure 5) 
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placed E. inebrians basal in genus Epichloë, supporting the possibility that the cluster common to most 
Epichloë species was lost on that basal branch to E. inebrians. However, a puzzle remains in that no 
genus other than Epichloë showed indications of paralogous EAS clusters. This may be just a matter of 
limited sampling, and we predict that a wider and deeper survey of the Clavicipitaceae will reveal 
paralogs related to the basal group of Epichloë EAS sequences. 
Paralogous dmaW genes are in fact evident in some of the Clavicipitaceae. Specifically, C. purpurea 
20.1 has two dmaW copies flanking a paralogous easF and located 94 kb and 98 kb from the EAS-cluster 
dmaW. Epichloë mollis also has a paralogous dmaW, which appears to be a pseudogene. However,  
these paralogues are due to relatively recent duplications and group with the respective Claviceps and 
Epichloë dmaW genes in phylogenetic analysis [43]. 
3.2. Mapping EAS Gene Gains and Losses 
Mapping genomic alternations onto the WFCE phylogeny (Figure 3) revealed repeated instances in 
which multiple EAS genes have been lost. The most extensive losses were eight genes in two separate 
instances resulting in gene sets for CC production: The branch to E. elymi and E. brachyelytri, and the 
branch to At. hypoxylon. The identification of remnant or pseudogene copies of other EAS genes 
supported the scenario of extensive gene loss, as inferred from the phylogeny. Losses of multiple EAS 
genes on numerous lineages have given rise to at least four distinct chemotypes in addition to the 
variations in ergopeptines. These gene losses add to the potential for ergot alkaloid diversification, 
together with neofunctionalization of lpsA (Table 2), and with easA variations to give agroclavine or 
festuclavine as precursors of ergot alkaloids and dihydroergot alkaloids, respectively, and easG 
variations to yield 8(S)-dihydroergot alkaloids (Figure 1) [17]. 
Interestingly, in almost all cases of EAS gene loss (Figure 3), all genes were lost or inactivated for a 
branch of the pathway, leaving only those EAS genes required for biosynthesis of the observed 
metabolites. In two instances, this process has given CC as the end product (or presumed end product), 
in one instance it has given EN rather than LAH, and in three instances it has eliminated the ergopeptine 
pathway. The only exception to this pattern is in C. fusiformis, which has apparently retained easH 
despite losing all other genes for late pathway steps both to ergopeptines and to EN and LAH. However, 
whether easH is transcribed or gives an active (but presumably useless) product in C. fusiformis is 
unknown. Among many natural strains, gene losses are similarly evident in indole-diterpene (IDT) and 
loline alkaloid (LOL) gene clusters with loss or inactivation of all other genes for downstream steps of 
the affected pathway branch [24,44,45]. Such common patterns suggest that there is selection against 
expression of enzymes in strains that lack their normal substrate. We speculate that expression of such 
enzymes may be directly harmful because the enzymes may catalyze reactions with substrates other than 
the missing natural substrate, thereby generating toxic products. 
3.3. Positional Changes of Clusters with Respect to Telomeres 
Also mapped to the WFCE phylogeny (Figure 3) are three changes in the EAS cluster positions 
relative to telomeres. Considering that the N. fumigata and basal Epichloë EAS genes are near telomeres 
(“subterminal”), it is parsimonious to propose this as the ancestral state. If so, internalization would have 
occurred on the branch that separates most of the Clavicipitaceae from the basal Epichloë EAS genes. 
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An interesting translocation event is evident on the branch to E. inebrians, whereby the EAS cluster was 
divided and at least one of the two resulting portions returned to a subterminal position. Interestingly, 
the cloA gene (designated B on the map in Figure 2) is situated such that its stop codon is a single base 
away from the telomere repeat array, implying that the telomere serves as a transcription terminator for 
that gene. The translocation event on the E. inebrians branch nicely illustrates the dynamics of 
subterminal regions of the chromosomes. Recalling that the IDT cluster—directing biosynthesis of the 
indole-diterpene, paxilline—is subterminal in the closely related E. gansuensis strain E7080 [24], it is 
particularly interesting to find two remnant IDT genes flanking the centromeric side of the subterminal 
EAS cluster in E. inebrians. It appears likely that the EAS cluster displaced most of the IDT cluster as it 
moved into the subterminal position. This supports an important role of subterminal regions in 
arrangements and rearrangements of secondary metabolism gene clusters. With that in mind, we would 
predict that most EAS cluster rearrangements occur in association with subterminal clusters, whereas 
internal EAS clusters are more stable. Evidence pertinent to that prediction is discussed later, in Section 5. 
3.4. Evolution of LpsC 
Assuming that the common ancestor of Clavicipitaceae and Trichocomaceae possessed the seven 
genes for early and intermediate biosynthetic steps, a parsimonious scenario would identify three 
branches for gene gains: one to N. fumigata, one to all Clavicipitaceae, and the third to Clavicipitaceae 
after splitting from the basal Epichloë EAS clade (Figure 3). In the context of our proposed paralogy, the 
last of these would have involved acquisition of the new genes, lpsC, easO and easP, on one of the 
branches after that split in the Clavicipitaceae. Interestingly, LpsC serves as an alternative to the LpsA 
subunit in interacting with LpsB as a component of a lysergyl peptide synthetase complex (Figure 1).  
A phylogenetic analysis of Lps subunit A domains (Figure 6) indicates that lpsC may be derived from a 
copy of the first module of lpsA fused to an R* (reductase) coding sequence. Thus, biosynthesis of EN 
and LAH seems to have evolved later than biosynthesis of the much more complex ergopeptines. 
3.5. Evolution of Module Specificity in LpsA 
The evolution of module specificity in LpsA subunits can also be mapped onto the WFCE (Figure 3) 
and lpsA A-domain (Figure 6) phylogenies. However, a crucial difference between WFCE and lpsA 
phylogenies is that lpsA A-domains consistently group P. ipomoeae and B. obtecta in a terminal clade, 
whereas WFCE groups P. ipomoeae with Claviceps spp. and places B. obtecta in a relatively basal 
position. This may be the result of lpsA paralogy due to duplications and losses (a scenario reminiscent 
of the tandemly duplicated lpsA genes in C. purpurea), or may simply be due to lineage sorting effects 
in the evolution of these lineages (as suggested by the short and poorly supported branch in the tefA 
phylogeny). To discuss LpsA module evolution, we now use single-letter abbreviations for the three 
specified amino acids in order of the modules 1, 2 and 3. The ancestral state could have been ALP or 
AVP, with module A2 changing specificity either on the basal Epichloë branch or on the lineage  
leading to the Claviceps/Periglandula/Balansia clade, respectively. During evolution of the 
Periglandula/Balansia clade, specificity of module 3 switched from P to A. What is especially 
interesting is that, within Claviceps, there is an accelerated diversification of modules 1 and 2, such that 
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the variant LpsA subunits specify the substrate combinations for at least 19 different ergopept(in)ines 
(Table 2). 
 
Figure 6. Phylogeny of the Lps subunit AMPylation domains. The phylogenetic tree was 
inferred by maximum likelihood on a nucleotide alignment of coding sequences. Methods 
are as in Figure 3. The specified substrates are given in parentheses as LA = lysergic acid, 
dihyroLA = dihydrolysergic acid, and standard abbreviations for common L-amino acids. 
The LpsA superscripts indicate single-letter codes for the amino acids specified by 
AMPylation domains of module 1, 2 and 3 (A1, A2 and A3), respectively. Functionality and 
specificity of M. robertsii LpsB and LpsC are unknown. The P. ipomoeae EAS cluster is 
shown at right with Lps genes and modules color-coded. 
4. Ergot Alkaloid Diversity within Epichloë Species 
4.1. Distribution of EAS Genes across Epichloë Species 
The distribution of the EAS locus is well understood within Epichloë species due to the availability 
of genomic and genotyping data (www.endophyte.uky.edu). Genome sequences (including draft 
genomes) for 54 isolates representing 10 described Epichloë species, two varieties, and five undescribed 
species have enabled comparisons of the EAS locus across a diverse collection of isolates with varying 
capabilities to produce ergot alkaloids [24,34,38,43,45,46]. Moreover, in recent studies, markers developed 
from the genome sequences have been used for PCR-based genotyping of endophyte-infected grass 
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collections for the presence of genes encoding key alkaloid biosynthesis pathway steps [10,47–52]. 
Compared to genome sequencing, PCR-based genotyping is less reliable in determining if a gene is 
functional, but the presence of full-length genes typically associated with EAS clusters for the 
metabolites CC, ERV or EN usually corresponds well to the production of the corresponding metabolite. 
The predictive power of this method is helped by the tendency for complete losses or large deletions in 
the nonfunctional alkaloid biosynthesis genes, and for the downstream genes to be partly or completely 
deleted as well [24]. 
The presence of EAS genes within Epichloë species has been observed in strains of at least 19  
(9 nonhybrid and 10 hybrid species) of the 35 taxa tested (including varieties and undescribed species) 
(Table 3). The EAS locus has a discontinuous distribution within Epichloë species. For example, not all 
E. festucae isolates are capable of producing ergovaline, since some isolates (e.g., E. festucae E434) lack 
the EAS locus. However, in addition to their discontinuous distribution, the EAS loci can differ in 
structural content. Strains capable of producing CC (e.g., E. elymi E56) only contain functional genes 
encoding the first four EAS pathway steps (DmaW, EasF, EasC and EasE) (Figure 1; Table 1), whereas 
ergovaline producers (e.g., E. festucae Fl1) have more complex EAS loci (EASERP) with at least 11 
functional genes present (Table 1). 
Many of the chemotype differences identified within the Epichloë species can be attributed to the 
presence or absence of genes encoding the key pathway steps, but there are some anomalies. Isolates, 
such as E. festucae strains E2368 and E189, E. amarillans E4668 and E. glyceriae E2772 appear to have 
complete EASERP clusters with no obvious deleterious mutations, yet ergot alkaloids have not been 
detected in host plants symbiotic with these isolates. Transcriptome (RNA-seq) analysis of  
E2368-infected meadow fescue (Lolium pratense) and tall fescue show that the EAS genes are not 
expressed in this strain, thus providing a clue to why the predicted alkaloid, ERV, is not produced [24]. 
Many endophytes can readily produce ergot alkaloids in planta but have a more limited and unreliable 
production in non-symbiotic culture conditions [53,54]. Histone methylation apparently helps repress 
expression of EAS and other alkaloid gene clusters when Epichloë species are grown in culture, since 
the EAS and LTM genes of E. festucae strain Fl1 were de-repressed under non-symbiotic culture 
conditions when two genes that encode histone H3 methylases were deleted [55]. 
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Table 3. EAS gene distribution within and between Epichloë species. 
Epichloë species a Host species Detection method b EAS gene variations (strains observed) c Reference 
Epichloë amarillans Agrostis hyemalis GT, DG, G 0* (4), (ERV) (1) [24] 
E. aotearoae Echinopogon ovatus G 0 (1) [24,43] 
E. baconii Agrostis tenuis, Calamagrostis villosa GT, G 0* (3) [43] 
E. brachyelytri Brachyelytrum erectum GT, G 0 (1), CC (3) [24] 
E. bromicola Bromus erectus, Bromus benekenii, Bromus tomentellus, Agropyron hispidus GT, DG, G 0* (5) [43] 
E. cabralii (H) Phleum alpinum Bromus laevipes G, GT 0 (1), (ERV) (2) [50] 
E. canadensis (H) Elymus canadensis GT, DG CC (1), ERV (1) [43,47] 
E. chisosa (H) Achnatherum eminens DG 0 (1) [43] 
E. coenophiala (H) Lolium arundinaceum GT, DG 0* (11), ERV (12), ERV (39) [43,49,51] 
E. elymi Elymus virginicus GT, G 0 (1), CC (1) [24] 
E. festucae Festuca trachyphylla, Festuca rubra subsp. rubra, Lolium giganteum GT, G 0 (1), ERV (1), (ERV) (2) [24] 
E. festucae var. lolii Lolium perenne GT, G ERV (2), (ERV) (1) [56,57] 
E. festucae var. lolii x E. typhina (H) Lolium perenne DG ERV (1) [43,58] 
E. funkii (H) Achnatherum robustum GT, DG CC (1) [43] 
E. gansuensis Achnatherum inebrians G 0 (1) [24] 
E. inebrians Achnatherum inebrians G EN, LAH (1) [24] 
E. glyceriae Glyceria striata GT (ERV) (2) [24] 
E. mollis Holcus mollis G ERV (1) [43] 
E. occultans (H) Lolium sp. (2x) GT 0 (3) [43] 
E. schardlii (H) Cinna arundinacea GT 0 (1) [59] 
E. siegelii (H) Lolium pratense DG 0 (1) [43] 
  
Toxins 2015, 7 1290 
 
 
Table 3. Cont. 
Epichloë species a Host species Detection method b EAS gene variations (strains observed) c Reference 
E. sylvatica Brachypodium sylvaticum GT 0 (2) [34] 
E. typhina  Lolium perenne, Dactylis glomerata G, GT 0 (3) [24,43] 
E. typhina ssp. clarkii Holcus lanatus GT ERV (1) unpublished 
E. typhina ssp. poae Poa nemoralis, Bromus laevipes GT, G 0 (3), ERV (1) [24,50] 
E. uncinata (H) Lolium pratense DG 0 (1) [43] 
E. sp. AroTG-2 (H) Achnatherum robustum GT EN (1) [10] 
E. sp. BlaTG-3 (H) Bromus laevipes GT 0* (1), CC (2) [50] 
E. sp. FaTG-2 (H) Lolium sp. (6x) GT, DG ERV (10), ERV (33) [43,49,51,60] 
E. sp. FaTG-3 (H) Lolium sp. (6x), (8X) GT, DG 0 (11) [43,51,60] 
E. sp. FaTG-4 (H) Lolium sp. (10x) GT, DG ERV (1), ERV (11) [43,51] 
E. sp. FcaTG-1 (H) Festuca campestris GT 0 (3) unpublished 
E. sp. FveTG-1 (H) Festuca versuta GT 0 (2) unpublished 
E. sp. PalTG-1 (H) Poa alsodes GT 0* (1) unpublished 
E. sp. PauTG-1 (H) Poa autumnalis GT 0 (1) unpublished 
a Endophytes that are known hybrids = (H); b Detection methods for the EAS genes DG = draft genome, G = genome, GT = PCR-based genotyping; c Number of independent 
strains evaluated. Alkaloids are abbreviated CC = chanoclavine I, ERV = ergovaline, EN = ergonovine, LAH = lysergic acid α-hydroxyethylamide, and are in bold face 
(product produced) or regular type (product predicted but not yet tested), or in parentheses (product predicted but undetected). 0 = No EAS genes identified, 0* = contains 
only remnants of EAS clusters; 0 and 0* are unable to produce ergot alkaloids. 
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4.2. Pseudogenes and Gene Remnants within the EAS Locus 
Pseudogenes and gene remnants have been identified within or adjacent to many of the described EAS 
clusters within the Clavicipitaceae. Most Epichloë species that are unable to produce ergot alkaloids lack 
functional EAS genes or only retain remnants of some EAS genes. For example, a remnant lpsA sequence 
is present in the genome sequences of E. amarillans strain E57, E. bromicola strain AL0434, and 
Epichloë coenophiala strains e4509, AR542 and AR584. Typically these lpsA remnants have multiple 
frameshifts, stop codons or both, and are flanked or even disrupted by AT-rich repeat sequences; or,  
in the case of E57, the gene is truncated at the telomere [24]. In comparison to E. bromicola strain AL0434, 
which has only an lpsA remnant, strain AL0426/2 has retained a greater number of EAS genes  
(Figure 7). The E. bromicola AL0426/2 genome assembly (www.endophyte.uky.edu) contains lpsB, 
easE, easF and easG (contig 634), but easE is a pseudogene in which part of the coding sequence is 
missing. Since dmaW and easC are also missing, the AL0426/2 isolate is not expected to produce ergot 
alkaloids. The identification of two independent EAS gene loss events in E. bromicola (strains AL0434 
and AL0426/2) suggests that this species may have greater EAS diversity than is currently recognized, 
but E. bromicola strains capable of producing ergot alkaloids have not yet been identified [61]. 
 
Figure 7. Remaining EAS genes and pseudogenes after independent losses in two  
E. bromicola isolates, AL0434 and AL0426/2. The AT-GC DNA contents are shown under 
the maps. Pseudogenes are represented by Ψ. 
4.3. Hybrids: EAS Gene Cluster Variations 
Compared to sexual strains or other haploids, the hybrid Epichloë species have a greater potential to 
contain EAS genes because each of the ancestors contributes genetic information. In addition, variations 
of the EAS locus within a hybrid can be due to copy number or differences within the inherited EAS 
cluster (EASCC vs EASERP clusters). Some, but not all isolates from the hybrid species,  
Epichloë canadensis, E. coenophiala, and E. sp. FaTG-2, contain two EAS copies (Figure 8). The  
E. canadensis isolate e4815 contains two EAS clusters—EASERP for ERV and EASCC—that are 
representative of the two contributing ancestors, E. amarillans and E. elymi, respectively. In contrast,  
E. canadensis isolate CWR34 contains a single EASCC cluster, contributed by its E. elymi ancestor. 
Mating-type gene differences between E. canadensis isolates e4815 and CWR34 clearly indicate that 
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they are the result of independent hybridizations, but it is unclear if CWR34 subsequently lost the  
E. amarillans EAS cluster, or if its particular ancestral strain of E. amarillans lacked EAS genes. 
 
Figure 8. Phylogeny of dmaW genes of Epichloë strains. The phylogenetic tree was inferred 
by maximum likelihood on a nucleotide alignment of coding sequences. Methods are as in 
Figure 3. The dmaW alleles are distinguished in hybrids that possess more than one copy 
with a letter that refers to the ancestral progenitor (a = E. amarillans, b = E. baconii-related 
Lolium associated Epichloë subclade, e = E. elymi, f = E. festucae, m = E. mollis-related and 
p = E. typhina subsp. poae. The dmaW gene of E. inebrians has been omitted in this analysis 
because the gene and EAS locus is more similar to that of P. ipomoeae than to those of other 
Epichloë species (see Figure 3). 
4.4. Gene Losses in Hybrids with Multiple Copies 
Some isolates of E. coenophiala are unable to produce ergot alkaloids because they only contain a 
remnant EAS locus (e.g., e4309, AR542 and AR584; Table 3) [51]. The E. coenophiala isolates known 
to produce ERV, such as isolates e19 and e4163, have two copies of the EAS clusters from two of the 
three contributing ancestors: E. festucae and the Lolium-associated Epichloë (LAE) subclade. 
Interestingly, the EAS clusters of both E. coenophiala isolates e19 and e4163 are structurally very similar 
with respect to AT content and repeat sequences, though they differ in which EAS genes are absent or 
inactive pseudogenes in each EAS cluster (Figure 9). The lpsB2 gene in e19 (from the E. festucae 
ancestor) is nonfunctional due to a frame shift within the coding region. The situation in e4163 is more 
complex in that neither EAS cluster is complete; EAS1 (from LAE) lacks lpsB1 and easE1, and EAS2 
(from E. festucae) includes a nonfunctional easG2. Therefore, since e4163 is able to produce ERV, each 
EAS cluster must functionally complement the genetic deficiencies of the other cluster. Epichloë sp. 
FaTG-2 isolates NFe45115 and NFe45079 are both capable of producing ERV, but EAS copy numbers 
differ; NFe45115 has one copy, whereas NFe45079 has two copies [49]. Recent genome sequence data 
have also revealed that NFe45079 contains only a single copy of lpsA, but all other genes are present in 
two copies. 
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Figure 9. Structures of the EAS clusters from two E. coenophiala strains, e19 and e4163. 
The AT-GC contents are shown under the maps. Gene names are abbreviated as in  
Figure 2. 
4.5. Endophyte Genetic Variation within a Single Host Species 
The associations of endophytes and hosts represent co-evolving associations as evidenced by the 
tendency for evolution of the Epichloë spp. to track evolution of their hosts [62]. It is interesting to note 
that sometimes a single host species has symbiotic associations with more than one endophyte species, 
but each individual plant will only host one endophyte genet. Tall fescue can be symbiotic with  
E. coenophiala, Epichloë sp. FaTG-2, FaTG-3 and FaTG-4, and strains representing each of these 
endophytes have different alkaloid profiles [43,51,60]. Elymus canadensis can be symbiotic with  
E. elymi and E. canadensis, and each of these endophytes also exhibits chemotype variation [47]. As we 
develop and refine high throughput methods to explore large host collections more thoroughly,  
more endophyte variation may be identified within a single host species. 
Recently Bromus laevipes, a bunchgrass native to California, was found to have independently 
formed symbiotic associations with three Epichloë species, the nonhybrid E. typhina subsp. poae 
(designated Bromus laevipes Taxonomic Group 1; BlaTG-1), a hybrid designated BlaTG-2, which 
appears to be phylogenetically similar to E. cabralii from Phleum alpinum, and another hybrid 
designated BlaTG-3 [50]. Endophyte diversity within this host collection was identified by PCR-based 
genotyping of the EAS, LOL, indole-diterpene/lolitrem (IDT/LTM) and peramine (PER) loci. The 
BlaTG-3 isolates could be separated into three genotypes (G1, G2, and G3) based on the EAS and mating 
type complement. Isolates considered BlaTG-3 G1 only contained dmaW, whereas BlaTG-3, G2, and 
G3, had different mating-type genes, but shared the same EAS gene complement (EASCC) in keeping 
with its ability to produce CC. In contrast, the complete EAS gene complement required for ERV 
production (EASERP) was identified within BlaTG-2, yet ergot alkaloids were not detected in plants with 
BlaTG-2. RT-PCR expression analyses of the EAS genes from BlaTG-2-infected plants indicated they 
were not expressed. Interestingly, although BlaTG-2 and E. cabralii from Phleum alpinum are  
hybrids with the same two ancestral Epichloë species, no EAS genes are present in characterized  
E. cabralii strains. 
Sleepygrass plants growing in the vicinity of Cloudcroft, New Mexico, U.S.A., are renowned for their 
narcotic effects on livestock because they can have high levels of the ergot alkaloids ergine and EN [63]. 
It is now clear that two endophyte species can be symbiotic with sleepygrass, E. funkii [64] and a so-far 
undescribed hybrid Epichloë species designated AroTG-2 [10]. Each of these endophytes has the EAS 
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complement and ability to produce different ergot alkaloids, either CC (EASCC) or ergine and EN 
(EASEN), respectively [10]. Phylogenetic analysis of dmaW groups the E. funkii gene in a clade with 
dmaW of the E. festucae clade (Figure 8). In contrast, AroTG-2 has a dmaW sequence more similar to 
that of E. inebrians from drunken horse grass than to that of other Epichloë species (data not shown), 
which is in keeping with the similarity of the alkaloids produced by these two endophyte species and 
their strong stupor-inducing effects on grazing livestock [11,63]. 
5. Synteny and Rearrangements in the EAS Loci 
5.1. Syntenic Regions of the EAS Loci 
Although functional EAS genes are always clustered, they are not always in a single cluster, 
arrangements of the genes are not highly conserved, and locations of the clusters can vary, some being 
subterminal (near chromosome ends), and others being internal and flanked on both sides by long regions 
rich in housekeeping genes (Figure 10). With the exception of the Epichloë species (discussed below), 
the degree of divergence in EAS gene arrangements, gene contents, and the pathway  
end-products generally relates to the degree of divergence between species. Thus, it is unsurprising that 
the EAS cluster arrangements and gene contents differ greatly in comparison of N. fumigata to the 
Clavicipitaceae. A surprisingly consistent feature is the arrangement and close linkage of easE and easF 
in all except E. elymi E56; even their Ar. benhamiae orthologues, respectively designated ARB_4648 
and ARB_4647, are adjacent but arranged tail to tail [18]. However, EAS gene arrangements and 
orientations are very similar in what we will call the “crown EAS clade” (Figure 3): Metarhizium spp. 
(including Metarhizium acridum, which is not shown), P. ipomoeae, B. obtecta, At. hypoxylon, Claviceps 
spp. and E. inebrians. Differences within the crown EAS clade were as follows: (1) an inversion of  
lpsB-easA segment in C. fusiformis relative to the others; (2) separation of the easH-lpsA segment from 
others in B. obtecta, due to an event that (based on remnant genes) occurred in a common ancestor of B. 
obtecta and At. hypoxylon; (3) breakage of the cluster in E. inebrians by a telomere introduced 
immediately downstream of cloA; and (4) several gene losses or inactivations that have resulted in 
changes in ergot alkaloid profiles, as discussed above. 
Despite the conserved arrangement of EAS genes in the aforementioned crown EAS clade, there is 
very limited synteny of flanking genes (Figure 2), except within the Claviceps subclade and, separately, 
within the B. obtecta/At. hypoxylon subclade. The only group of orthologous genes that flanks most 
members of the crown EAS clade is represented in C. purpurea 20.1 by AET79176 (GenBank accession 
number; labeled with asterisks in Figure 2) and is similarly positioned in all except E. inebrians, which 
has its AET79176 orthologue at the opposite end of the cluster. With the possible exceptions of  
At. hypoxylon B4728 and E. festucae E2368, the AET79176 orthologue was linked to EAS in every strain 
that had one. In B4728, it is also possible that the gene is linked to the EAS cluster, but at >75 kb from 
easC (the AET79176 orthologue being near the middle of the 123,479-bp contig00086, which is 
otherwise very AT-rich and lacks other identifiable genes). So far, there is no putative function or 
conserved signature domain for AET79176, but it might warrant future investigation for a possible role 
in the regulation of EAS genes or in a biosynthetic role yet to be identified. 
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Figure 10. Structures of representative EAS loci showing synteny of EAS genes between 
species. Genes are colored to represent the stage of the pathway for the encoded product  
(see Figures 1 and 2). Pseudogenes are represented by Ψ and white-filled arrows. Gray 
polygons link orthologous genes and gene blocks but are not meant to imply particular 
phylogenetic relationships. The EAS crown clade includes clusters from At. hypoxylon,  
B. obtecta, C. purpurea, C. fusiformis and P. ipomoeae. 
5.2. Epichloë Species Have More EAS Loci Rearrangements 
The Epichloë species show the greatest variation in cluster organization (Figure 10). Even EASERP 
clusters, which possess apparently functional forms of 11 EAS genes, show extreme rearrangements of 
Toxins 2015, 7 1296 
 
 
gene positions relative to each other and to the telomeres. (The actual linkage and order of the contigs 
containing EAS genes was established for E. festucae strains E2368 and Fl1 [24] but could not be 
determined for other genome sequences when not assembled into scaffolds.) Also highly variable among 
Epichloë EAS clusters was the organization of their extensive, AT-rich, repetitive sequences, which may 
directly facilitate cluster instability and rearrangements, and in some cases cause partial or entire deletion 
of genes giving, for example, EASCC clusters (Figures 2 and 9) [24]. In addition, within the Epichloë 
species, there is a strong tendency for the EAS locus to be retained at the subterminal region, even though 
the order of genes relative to the telomere (chromosome end) can differ. 
Miniature inverted-repeat transposable elements (MITEs) are prevalent in Epichloë species [57], and 
have been identified in the promoters of some EAS genes with expansion in the EASCC clusters associated 
with dmaW and easC. The repetitive AT-rich sequences and prevalence of MITEs are also associated 
with the gene clusters for biosynthesis of other alkaloid classes; namely, IDT/LTM (indole-diterpenes) 
and LOL (lolines) [24]. The presence of long transposon-derived repeat blocks seems consistent with the 
subterminal location of telomere-linked clusters like EAS and IDT/LTM, but the fact that they also feature 
prominently in the Epichloë LOL clusters, which are typically internal with extensive genic regions 
flanking both ends, suggests that this is a more general feature of alkaloid clusters [24]. 
5.3. The Complex History of EAS Loci 
Although not by any means restricted to subtelomeric and subterminal regions, blocks of  
transposon-derived repeats are features of these genomic regions in fungi [65,66], and such regions are 
prone to considerable instability and gene duplication events [67,68]. A subterminal location appears to 
be the ancestral state of the EAS cluster, considering that it is a shared feature of N. fumigata and the 
basal EAS clade in Clavicipitaceae; namely, the clade comprised of the majority of Epichloë EAS clusters 
(Figure 3). Thus, increased stability, particularly of the EAS core containing early- and mid-pathway 
genes, seems to be in keeping with the shift from subterminal to internal location in the common ancestor 
of the crown EAS clade. Nevertheless, the differences in flanking housekeeping genes between the 
Claviceps subclade and the B. obtecta/At. hypoxylon subclade, plus indications of gene duplication in  
C. purpurea, indicate additional complexity in the history of the EAS clusters. In C. purpurea, the 
duplication of lpsA has enabled its neofunctionalization to greatly enhance the diversity of ergopeptine 
products (Figure 10). Interestingly, 55-73 kb downstream of lpsC in the C. purpurea genome are two 
additional copies of dmaW and easF (Figure 11), suggesting that gene duplication has been a particularly 
dynamic evolutionary process in C. purpurea in addition to providing an attractive explanation for the 
fact that most of the known ergopeptin(in)es are reported from this species. Furthermore, the dmaW and 
easF duplications are close to a recQ helicase pseudogene, and reflecting their typical locations, recQ 
helicase genes are also called telomere-linked helicase genes (TLH). (For example, a recQ helicase gene 
is located near the EAS-linked telomere of N. fumigata, as shown in Figures 2 and 9). In C. purpurea, 
the association of a recQ helicase pseudogene with duplicated EAS genes and in the vicinity of the EAS 
cluster suggests more recent evolutionary history associated with a chromosome end than implied in our 
phylogenetic inferences (Figure 3). Thus, repeated shifts between subterminal and internal locations may 
have characterized EAS clusters in the Clavicipitaceae, and perhaps especially in C. purpurea as a driver 
of ergopeptine diversification. 
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Figure 11. Gene map showing dmaW and easF paralogues in the region flanking the EAS 
locus from C. purpurea strain 20.1. The genes for recQ helicase and paralogues of dmaW 
and easF are shown in black, and the genes pertaining to the EAS cluster are color-coded 
based on position of the encoded step within the pathway. For other genes, the locus_tag 
names (GenBank) are CPUR_04108, CPUR_04107, etc., where only the last four digits  
are shown. Names of EAS genes are abbreviated as in Figure 2. 
6. Conclusions 
Our understanding of ergot alkaloid biosynthesis has greatly increased through genomics and 
dissection and manipulation of the biochemical pathway. The genetic basis for ergot alkaloid chemotype 
diversification can be equated to the presence or absence of genes within the EAS loci that result in the 
EAS gene complements for, e.g., EASCC, EASEC, EASFC, EASERP, EASEN/ERP and EASLAH/ERP. 
Neofunctionalizing changes affecting substrate or product specificity of key enzymes, such as EasA 
(isomerase versus reductase isoforms), CloA and LpsA, also increase pathway diversification. 
Phylogenetic analysis of the genes dmaW, easF, easC and easE, which are common to all ergot 
alkaloid producers, has provided insight into the gene gains and losses that drive chemotypic 
diversification. In addition, phylogenetic relationships of the EAS genes are not congruent with those of 
housekeeping gene (e.g., tefA) phylogeny, as the majority of the Epichloë EAS genes (excluding those 
from E. inebrians) do not subtend the Claviceps clade and may represent paralogous EAS clusters. What 
also stands out among the sequenced Epichloë strains is the large amount of EAS-associated AT-rich 
repetitive sequences, in comparison to the EAS loci from the other Clavicipitaceae and N. fumigata. 
These repetitive sequences, as well as subterminal locations, have likely impacted the Epichloë EAS 
gene content and organization. We have also presented evidence above (Section 5) that subterminal 
locations are associated with gene duplication and neofunctionalization even in the evolution of the 
currently internal EAS cluster of C. purpurea. 
Unique to the Epichloë species is the tendency for hybrid formation, and in this process one or more 
of the ancestors may contribute EAS clusters. For some hybrid strains, the individual EAS contribution 
is incomplete, yet if two copies are present, each EAS cluster can functionally complement the genetic 
deficiencies of the other clusters. 
Genome sequence comparisons between species and strains show that the EAS loci can vary 
considerably based on distribution, gene content, gene order, and associated repeat content. Variations 
identified across multiple EAS loci are all in keeping with the overall natural chemotype diversity that 
has been identified within the Clavicipitaceae and the Trichocomaceae, and likely provides important 
selective advantages for many of the species in these families. 
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